CA2672153A1 - Polyphenol containing compositions - Google Patents

Polyphenol containing compositions Download PDF

Info

Publication number
CA2672153A1
CA2672153A1 CA002672153A CA2672153A CA2672153A1 CA 2672153 A1 CA2672153 A1 CA 2672153A1 CA 002672153 A CA002672153 A CA 002672153A CA 2672153 A CA2672153 A CA 2672153A CA 2672153 A1 CA2672153 A1 CA 2672153A1
Authority
CA
Canada
Prior art keywords
polyphenol
liposomes
pharmaceutical composition
cancer
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002672153A
Other languages
English (en)
French (fr)
Inventor
Raymond Michel Schiffelers
Josbert Maarten Metselaar
Gerrit Storm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Utrecht Holding BV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2672153A1 publication Critical patent/CA2672153A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002672153A 2006-12-11 2007-12-11 Polyphenol containing compositions Abandoned CA2672153A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06077189A EP1932517A3 (en) 2006-12-11 2006-12-11 Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof
EP06077189.6 2006-12-11
PCT/NL2007/000310 WO2008072954A2 (en) 2006-12-11 2007-12-11 Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof

Publications (1)

Publication Number Publication Date
CA2672153A1 true CA2672153A1 (en) 2008-06-19

Family

ID=38162226

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002672153A Abandoned CA2672153A1 (en) 2006-12-11 2007-12-11 Polyphenol containing compositions

Country Status (6)

Country Link
US (1) US20100143452A1 (enExample)
EP (2) EP1932517A3 (enExample)
JP (1) JP2010512384A (enExample)
AU (1) AU2007332272A1 (enExample)
CA (1) CA2672153A1 (enExample)
WO (1) WO2008072954A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2210504A1 (en) * 2009-01-27 2010-07-28 Nestec S.A. Composition comprising chicoric acid and/or derivatives thereof
US20100261662A1 (en) * 2009-04-09 2010-10-14 Endologix, Inc. Utilization of mural thrombus for local drug delivery into vascular tissue
CN102711743A (zh) 2009-10-22 2012-10-03 Api起源有限责任公司 含有黄酮类的组合物的制备和使用方法
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
DE102011114951A1 (de) 2011-10-06 2013-04-11 Forschungszentrum Jülich GmbH Molekülmischung, umfassend eine amphipathische Molekülsorte A, welche im hydrophilen Bereich elne positive Gesamtladung aufweist und eine amphipathische Molekülsorte B sowie ein Polyphenol C, Verfahren zur Herstellung der Molekülmischung und deren Verwendung
RU2477635C1 (ru) * 2012-02-14 2013-03-20 Глеб Иванович Кирьянов Способ получения инцистерола
WO2014085914A1 (en) * 2012-12-06 2014-06-12 Misudan Enterprises Inc. Topical liposome compositions containing phenolic anti-inflammatory agents and their methods of preparation
JP6708376B2 (ja) * 2015-07-10 2020-06-10 株式会社山田養蜂場本社 ＩＦＮ−γ及び／又はＩＬ−１７の産生抑制剤、並びにＴｈ１細胞及び／又はＴｈ１７細胞の分化抑制剤
WO2017061627A1 (ja) * 2015-10-09 2017-04-13 三栄源エフ・エフ・アイ株式会社 ポリフェノール含有固体組成物
US20170172921A1 (en) * 2016-12-14 2017-06-22 Mahmoud Reza Jaafari Polyphenolic compounds encapsualated in long circulating liposomes and use thereof
CN107007569B (zh) * 2017-03-23 2019-08-30 徐州医科大学 一种载槲皮素和白藜芦醇的磁性脂质纳米粒及其制备方法
JP2017148804A (ja) * 2017-05-10 2017-08-31 国立研究開発法人農業・食品産業技術総合研究機構 還元性有機物を原料とするフェントン反応触媒
TR201720642A2 (tr) * 2017-12-18 2019-07-22 Univ Yeditepe Güdümlü kafe yüklü mi̇krovesi̇küler kanser i̇laci ve bunun geli̇şti̇ri̇lmesi̇ yöntemi̇
CN109320661A (zh) * 2018-10-21 2019-02-12 桂林理工大学 一种交联蔗渣木聚糖咖啡酸酯-g-AM/MMA的合成方法
KR102120329B1 (ko) * 2019-06-12 2020-06-09 브렉소젠 주식회사 레스베라트롤을 포함하는 줄기세포 유래 엑소좀 생성 촉진 및 줄기세포능 증가용 조성물
GB201912760D0 (en) * 2019-09-05 2019-10-23 Healx Ltd Treatment
CN112716933A (zh) * 2021-01-25 2021-04-30 河南省洛阳正骨医院（河南省骨科医院） 7-羟基黄烷酮在制备促进青少年骨骼生长药物中的应用
KR20240039092A (ko) * 2021-06-01 2024-03-26 아이디어 바이오, 엘엘씨 안구 약물을 위한 연장 방출 약물 전달 시스템 및 사용 방법
CN113616603A (zh) * 2021-09-06 2021-11-09 江西科技师范大学 一种低能热稳定的脂质体纳米粒及其制备方法与应用
CN113749116B (zh) * 2021-09-27 2022-08-02 四川大学 抑藻材料及其应用
CN116406819B (zh) * 2021-12-31 2026-06-30 湖南楚禾康生物科技有限公司 多酚化合物或其衍生物在制备具有抑制电子烟致癌作用的添加剂中的应用
JP7884236B2 (ja) * 2022-02-24 2026-07-03 地方独立行政法人青森県産業技術センター 細胞サイズリポソーム、プロシアニジン濃度推定方法、およびプロシアニジン濃度測定方法
CN117582417A (zh) * 2022-08-09 2024-02-23 湖南健瑞医药科技有限公司 药物-脂质颗粒及其制备方法和应用
CN117582511A (zh) * 2022-08-09 2024-02-23 湖南健瑞医药科技有限公司 金属-磷脂复合物颗粒及其制备方法与应用
CN119138535A (zh) * 2024-09-26 2024-12-17 上海镜观生物科技有限公司 基于Xu5P提高剂的肿瘤抑制益生菌功能饮料及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2817334A (en) * 1954-11-24 1957-12-24 Sajeck George Air demand equipment
US5736155A (en) * 1984-08-08 1998-04-07 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
FR2628317B1 (fr) * 1988-03-09 1991-11-08 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
DE68916439T2 (de) * 1988-10-05 1994-10-20 Vestar Inc Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens.
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5714163A (en) * 1994-06-27 1998-02-03 Nexstar Pharmaceuticals, Inc. Vinca alkaloid vesicles with enhanced efficacy and tumor targeting properties
EP0825852B1 (en) * 1995-04-18 2004-07-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition
GB9717905D0 (en) * 1997-08-22 1997-10-29 Univ Aston Lipid-containing compositions and uses thereof
US6197834B1 (en) * 1998-09-01 2001-03-06 Northeastern Ohio Universities College Of Medicine Method of inhibiting formation of infectious herpes virus particles
CA2346879A1 (en) * 1998-09-16 2000-04-27 Alza Corporation Liposome-entrapped topoisomerase inhibitors
JP2002543134A (ja) * 1999-04-29 2002-12-17 アルザ・コーポレーション 薬物保持率を改善するためのリポソーム組成物
US20050260257A1 (en) * 2000-06-09 2005-11-24 Molecutec Licensing Llc Prophylactic, therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions
US20060127505A1 (en) * 2002-01-16 2006-06-15 David Haines Anti-inflammatory formulations
US7273951B2 (en) * 2003-05-30 2007-09-25 Astellas Pharma Inc. Polyhydroxy phenols and their use in binding p-selectin
WO2005063213A1 (en) * 2003-12-19 2005-07-14 Biodelivery Sciences International, Inc. Rigid liposomal cochleate and methods of use and manufacture
TW200618820A (en) * 2004-11-05 2006-06-16 Alza Corp Liposome formulations of boronic acid compounds
WO2006068759A2 (en) * 2004-11-22 2006-06-29 Magellan Companies, Inc. Liposomes containing phytochemical agents and methods for making and using same

Also Published As

Publication number Publication date
EP2124896A2 (en) 2009-12-02
WO2008072954A2 (en) 2008-06-19
WO2008072954A3 (en) 2008-10-02
EP1932517A2 (en) 2008-06-18
AU2007332272A1 (en) 2008-06-19
JP2010512384A (ja) 2010-04-22
US20100143452A1 (en) 2010-06-10
EP1932517A3 (en) 2008-07-16

Similar Documents

Publication Publication Date Title
US20100143452A1 (en) Polyphenol containing compositions
JP4463551B2 (ja) 改良された生物学的利用能を有する製剤における高分子量で親油性で経口摂取可能な生物活性物質
Parisi et al. Polyphenols and their formulations: Different strategies to overcome the drawbacks associated with their poor stability and bioavailability
Bilia et al. Vesicles and micelles: Two versatile vectors for the delivery of natural products
Ozkan et al. Encapsulated phenolic compounds: Clinical efficacy of a novel delivery method
Muller et al. Delivery of natural phenolic compounds for the potential treatment of lung cancer
Saraf Applications of novel drug delivery system for herbal formulations
Pecorini et al. Polymeric systems for the controlled release of flavonoids
Dwivedi et al. Progressive journey of phytosomes: preparation, characterization, patents, clinical trials & commercial products
Sardarabadi et al. Nanophytomedicine: A promising practical approach in phytotherapy
Salunkhe et al. Herbal liposomes: natural network for targeted drug delivery system
Borowy-Borowski et al. Unique technology for solubilization and delivery of highly lipophilic bioactive molecules
Alabrahim et al. A multifaceted review on extraction optimization, nanoformulation, and chemical modification approaches to enhance the yield, bioavailability, and health effects of xanthones
Saleemi et al. Phytosomes used for herbal drug delivery
CN106692056A (zh) 以甘草酸类化合物为膜材的空白脂质体、制备方法及应用
EP3283045B1 (en) One-step method for production of ultra-small lipid structures
KR101851470B1 (ko) 퀘세틴이 함유된 유방암 예방 및 치료를 위한 약제학적 조성물
US20170172921A1 (en) Polyphenolic compounds encapsualated in long circulating liposomes and use thereof
CN108685944A (zh) 包含活体染料的药物组合物及其应用
CN108685926A (zh) 包含化学消融剂和生物活性苷的药物组合物及其用途
Upase Amar et al. A review on Phytosome loaded with novel herbal drug and their formulation, standardization and applications
Chen Nanocontainers for the encapsulation and delivery of antioxidants/nutrients to food
EP4698155A1 (en) Oil free lipid nanoparticles for stabilizing hydrophobic agents and methods of use thereof
WO2023129025A2 (en) A functional food supplement for strengthening the immune system
Isacchi Micro-and nano-carriers to improve technological andbiopharmaceutical properties of drugs from plants

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20131211